首页> 中文期刊> 《国际医药卫生导报》 >鼻内窥镜下鼻腔泪囊吻合术联合新型硅胶管和丝裂霉素C治疗慢性鼻泪管阻塞30眼效果观察

鼻内窥镜下鼻腔泪囊吻合术联合新型硅胶管和丝裂霉素C治疗慢性鼻泪管阻塞30眼效果观察

摘要

目的 观察鼻腔泪囊吻合术联合新型硅胶管和丝裂霉素C治疗鼻泪管阻塞的临床疗效.方法 60眼慢性鼻泪管阻塞,采用泪囊鼻腔吻合术联合新型硅胶管,随机抽取30眼术中使用丝裂霉素C,对照组30眼未使用丝裂霉素C.结果 术后随访3~12个月.丝裂霉素组有效率为93.3%;对照组有效率为70.0%,差异有显著性(P<0.05).结论 鼻腔泪囊吻合术联合新型硅胶管加丝裂霉素C治疗鼻泪管阻塞操作安全、创伤小、疗效好,容易掌握和推广.%Objective To observe the clinical efficacy of dacryocystorhinostomy combined with novel silica gel tube and mitomycin C in the treatment for nasolacrimal duct obstruction.Methods 60 eyes with chronic nasal obstruction were performed dacryocystorhinostomy combined with novel silica gel,combined with nasolacrimal intubation and mitomycin C,a random sample of 30 eyes used mitomycin C,other 30 eyes in the control group did not use mitomycin C.Results The postoperative follow up ranged from 3 to 12 months.For the 30 eyes using mitomycin C,the cure rate was 93.3%,while the cure rate in 30 eyes in the control group was 70.0%,the difference was statistically significant(P< 0.05).Conclusion Dacryocystorhinostomy combined with novel silica gel tube and mitomycin C in the treatment for nasolacrimal duct obstruction is safe,with small trauma and good effect,and easy to be mastered and to have promotion.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号